FIBROGEN INC — Director's Dealing 2016

Nov 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-11-08

Reporting Person: Yu K Peony (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-08	Common Stock	M	2000	$3.50	Acquired	208502	Direct
2016-11-08	Common Stock	M	2700	$5.95	Acquired	211202	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-08	Stock Option (Right to Buy)	$3.50	M	2000	Disposed	2021-06-07	Common Stock (2000)	Direct
2016-11-08	Stock Option (Right to Buy)	$5.95	M	2700	Disposed	2022-06-27	Common Stock (2700)	Direct

Footnotes

F1: Fully vested.